Sternal Closure Systems Market – By Product, By Material, By Procedure, By End Use – Global Forecast, 2025 – 2034

Sternal Closure Systems Market Size

The global sternal closure systems market was valued at USD 2.6 billion in 2024 and is projected to exhibit 5.3% CAGR from 2025-2034. The worldwide spread of cardiovascular disease, such as coronary artery disease and congenital heart disease, has made open-heart surgery, especially median sternotomies, more prevalent.
 

For example, heart disease, as estimated by the World Health Organization (WHO), causes 17.9 million deaths every year. Additionally, the Centers for Disease Control and Prevention (CDC) reports that approximately 659,000 U.S. individuals die each year from heart disease, resulting in many cardiac procedures. There are various cardiac operations that call for effective closure methods to create stability after operation and minimize complications. Demand for sternal closure systems is increasing further due to aging populations and widening healthcare access within regions. The mounting disease burden highlights the urgent need for evolved sternal closure systems in cardiac surgery.
 

Additionally, refinements in sternal closure devices as fixed plate systems, resorbable technology, and antimicrobial-coated devices have added to operating results. New systems minimize the risk of infection and improve healing and comfort for patients. Applications by surgeons using the technologies increased success rates during procedures and decreased stay times within the hospital, ensuring market development. The striking decrease in post-surgical complications demonstrates the effectiveness of advanced sternal closure systems in improving patient outcomes.
 

Sternal closure devices and materials are medical devices and materials applied to stabilize and close the breastbone (sternum) following surgeries like median sternotomy, which commonly occurs in thoracic and cardiac surgeries. The systems are designed to hold the halves of the sternal halves to facilitate sufficient healing, prevent dehiscence (reopening), and reduce the risk of infection or mechanical complications. They include closure tools like wires, rigid plates, screws, clips, and cables, and bone cement used during sternal reconstruction or reinforcement.
 

Sternal Closure Systems Market Trends

• The market is witnessing a growing adoption of high-end materials such as Polyether Ether Ketone (PEEK) and titanium. These possess superior biocompatibility, corrosion resistance, and MRI imaging compatibility.
   
• The interlocking feature in combination with stiff plate systems is helping to enhance sternal closure procedures' stability, thereby yielding better patient outcomes and minimizing postoperative complications.
   
• Additionally, the growing demand for minimally invasive cardiac procedures is driving the demand for advanced sternal closure systems. Such procedures minimize surgical trauma, hospitalization, and hasten patient recovery.
   
• Manufacturers are developing devices compatible with smaller incisions while maintaining effective sternal stabilization.
   
• The market for sternal closure systems is evolving with increasing demand for patient-specific devices that are tailor-made to fit individual anatomies and surgical needs.
   
• In addition, companies are investing in technology to create custom-made implants and closure systems with an aim to develop more accurate fit and reducing complications.
   

Trump Administration Tariffs

• The imposition of tariffs on Chinese sourced components and materials of medical devices are expected to have consequence of increasing the cost for U.S. manufacturers of sternal closure systems.
   
• The imposition of these tariffs on components that are essential like titanium, surgical stainless steel, and polymers with specific properties is expected to cause significant disruptions in market expansion.
   
• This may lead to the increasing costs being passed on to the end users such as hospitals and other healthcare providers which are expected to pay higher costs for the sternal closure systems.
   
• Tariffs may disrupt international supply chains of medical device manufacturers, especially those in the Asia-Pacific region. Higher compliance cost, customs delay, and complex trading rules can impact the availability of inputs.
   
• While larger medical device companies may be able to negotiate price and expand their base of suppliers, smaller sternal closure market manufacturers are expected to keep lower profit margins.
   

Sternal Closure Systems Market Analysis

Based on product, the market is bifurcated into closure devices and bone cement. The closure devices segment is further sub-segmented into wires, plates and screws, and clips and straps. The closure devices segment dominated the market with the largest revenue share of 89.8% in 2024.
 

• Constant augmentation in open-heart surgeries like coronary artery bypass grafting and heart valve replacement boosts demand for sternal closure devices.
   
• For example, the National Heart, Lung, and Blood Institute reports that over 2 million people worldwide receive open-heart surgery annually. These procedures require median sternotomy; therefore robust closure systems are essential.
   
• As cardiovascular disease remains the major cause of mortality worldwide, the demand for successful bone fixation after surgery continues to increase, requiring closure devices in recovery from cardiac surgery. This high surgical volume attests to the growing significance of reliable sternal closure systems.
   
• Further, advanced surgical approaches and stiff fixation methods in closures, especially for complicated cases, are highly recommended by numerous cardiac surgery guidelines which further facilitates adoption of closure devices.
   

Based on material, the sternal closure systems market is segmented into stainless steel, titanium, and polyether ether ketone (PEEK). The stainless steel segment dominated the market with the largest revenue of USD 1.4 billion in 2024.
 

• Stainless steel sternal closure systems are a cost-saving alternative to titanium and PEEK-based systems for use in cost-preventive healthcare practice and areas. Stainless steel satisfies the demands of a mechanical strength and hardness required for routine use in surgery without a high price tag.
   
• This blend of price and performance renders stainless steel the first choice in public hospitals and low-to-middle income nations endeavoring to expand access to cardiothoracic surgery.
   
• Moreover, stainless steel closure system material properties make it possible to efficiently sterilize without losing its structural integrity and thus facilitate cost-saving through bulk buying or restricted reuse measures.
   
• Their stability at sterilization temperatures and mechanical stress favors repeated use in some regulatory settings, adding to their cost-effectiveness in high-volume surgical facilities.
   

Based on procedure, the sternal closure systems market is segmented into median sternotomy, hemistemotomy, and bilateral thoracotomy. The median sternotomy segment dominated the market with the largest revenue of USD 1.9 billion in 2024.
 

• Median sternotomy is the standard method of surgery for open-heart surgery, such as coronary artery bypass grafting (CABG), valve replacement, and heart transplant. The widespread surgery technique generates a continuous demand for sternal closure systems.
   
• The rising prevalence of cardiovascular disease worldwide adds to increased volumes of sternotomy procedures, growing the market for specialized closure devices that ensure proper healing and reduce sternal complications.
   
• The growing number of elderly people is also driving the demand of open-heart surgeries. The elderlies are often at greater risk of developing complications from illnesses like osteoporosis and diabetes. The United Nations estimates that by 2050, one in every six individuals worldwide will be older than age 65, compared to one in eleven in 2019.
   
• Furthermore, based on the National Institutes of Health (NIH), roughly 75% of HF admissions are of individuals aged 65 years or older, with over 50% presenting in individuals 75 years or older. This highlights the paramount importance of advanced closure systems specifically for this age group.
   
• Additionally, median sternotomy is ideal for wide range of procedures such as valve repair/replacement, congenital heart defect corrections, and coronary artery bypass grafting, which ensures the dominance of the segment.
   

Based on end use, the sternal closure systems market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment dominated the market with a share of 80% in 2024.
 

• The application of advanced sternal closure systems with antimicrobial coatings, rigid fixation, and improved biocompatibility reduces infection risks. Hospitals increasingly implement these systems to comply with regulatory standards and enhance patient safety indicators, which drives the use of sternal closure systems across these acute care facilities.
   
• In addition, there is greater pressure placed on hospitals to reduce infection rates for invasive surgeries, particularly those high-risk surgeries such as median sternotomy. Surgical site infections (SSIs) result in longer hospital stay, readmission, and treatment costs. As a result, to avoid SSIs, the demand for advanced sternal closure systems is high across hospitals.
   
• The widespread implementation of Enhanced Recovery After Surgery (ERAS) protocols within hospitals aims to improve outcomes from surgery and reduce healthcare expenditure. Sternotomy closure devices that maximize healing velocity, allow for early mobilization, and reduce post-operative complications, adhering to the protocols of value-based care.
   
• These systems also appeal to hospitals by reducing resource utilization, optimizing bed turnovers, and enhancing patient satisfaction scores, that are key elements in value-based care delivery.
   

North America: The U.S. sternal closure systems market is projected to grow significantly from USD 1.1 billion in 2024 to USD 1.7 billion by 2034.
 

• The U.S. has among the highest cardiovascular disease rates in the world and observes large number of open-heart surgeries yearly. The Centers for Disease Control and Prevention (CDC) reveals that approximately 659,000 individuals in the U.S. perish from heart disease annually, contributing to 1 out of every 4 deaths.
   
• Median sternotomy is needed for surgical procedures like CABG and valve replacement, and therefore, dependable sternal closure systems are necessary for these procedures. These conditions and the aging population further sustain surgical volume and closure system demand among U.S. healthcare institutions. The persistence of such disease burden underscores the imperative for successful sternal closure solutions for cardiosurgical procedures.
   
• The Centers for Medicare & Medicaid Services (CMS) value-based reimbursement model also puts a penalty on hospitals for avoidable readmissions, especially in the case of cardiac surgery. Sternal dehiscence or wound infection are among complications which usually become the cause of costly readmissions.
   
• U.S. hospitals have subsequently adopted advanced sternal closure systems that decrease such complications and enhance recovery outcomes, in keeping with objectives for cost-effective, quality healthcare delivery, driving the revenue growth in the market.
   
• Furthermore, U.S. cardiac surgeons stay well-informed and practice evidence-based medicine, and clinical guidelines recommend sternotomy closure with sternal fixation, especially in high-risk cases which calls for high adoption of sternal closure devices.
   

Europe: The sternal closure systems market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The UK's National Health Service (NHS) emphasizes minimizing post-operative complications and inpatient stays length, to optimize hospital resources. The use of sophisticated sternal closure systems, such as rigid fixation devices, facilitates better patient outcomes and early discharge, which drives their adoption in UK.
   
• These products reduce complications like sternal dehiscence and wound infection, allowing hospitals to achieve quality goals while maximizing resource use under NHS cost limits.
   
• Further, with the increasing number of elderly people in the UK, the incidence of heart valve disease, coronary artery disease, and other cardiac diseases amenable to surgery has also risen. For example, as per the House of Commons Library, in 2022, there were 12.7 million individuals aged 65 and above, making up 19% of the population of the UK.
   
• They face increased risk for compromised healing of the bones and surgical complication that requires better stabilization through more complex sternal closing systems. Hence, the above-mentioned factors propels the market growth in the country.
   

Asia Pacific: Japan sternal closure systems market is anticipated to witness lucrative growth between 2025 – 2034.
 

• The aging population in Japan contributes to the largest percentage among developed countries. For example, as per the Japanese Ministry of Health, persons aged 65 years and older comprised about 30% of the total Japanese population in 2023.
   
• The elderly population is most susceptible to cardiovascular diseases, such as aortic stenosis and coronary artery disease, that often necessitate median sternotomy interventions.
   
• Moreover, as per the NIH, cardiovascular diseases are responsible for about 28.2% of all fatalities in Japan. The high risk of sternal complications in elderly patients has led surgeons to implement sophisticated closure systems that ensure better bone fixation and shorter recovery times, thus leading to better patient outcomes among Japan's elderly population.
   

Middle East and Africa: The Saudi Arabia sternal closure systems market is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia has high prevalence rates of diabetes, obesity, and hypertension in the Middle East, making it more likely to have cardiovascular diseases needing surgical intervention. For example, the International Diabetes Federation states that the overall prevalence of diabetes was 17.7% in Saudi Arabia in 2021.
   
• Saudi Vision 2030 includes large-scale investments in building healthcare infrastructure, including cardiac centers and tertiary-level hospitals. Establishment of new hospitals and modernization of the old ones involve advanced surgical technology like advanced sternal closure systems.
   
• This governmental program to enhance healthcare delivery and clinical outcomes has increased the application of rigid fixation systems and innovative closure techniques in public and private healthcare facilities, driving the revenue growth in the country.
   

Sternal Closure Systems Market Share

The market has a dynamic mix of international and domestic players providing innovative solutions to meet the growing demand for advanced systems for the growing patient population. Companies such as Johnson & Johnson, Zimmer Biomet, KLS Martin, Stryker, and B. Braun are some of the dominant competitors in the market accounting for a combined market share of approximately 65%. Competition in this area arises from continuous technological developments and the ability to offer customized solutions for various sternal closure system applications.
 

In developing nations, due to the priority given to cost, multinational companies are squeezed to offer sternal closure systems that are both affordable and of quality. Domestic manufacturers take advantage of this demand by providing cost effective alternatives, which make multinationals alter their price strategy while maintaining the safety, ruggedness, and regulatory acceptability of the products.
 

Sternal Closure Systems Market Companies

Some of the eminent market participants operating in the sternal closure systems industry include:

• Able Medical
• Abyrx
• Acumed
• B. Braun
• IDEAR
• Jace Medical
• Jeil Medical
• Johnson & Johnson
• Kinamed
• KLS Martin
• Orthofix
• Praesidia
• Stryker
• Waston Medical
• Zimmer Biomet
   
• Johnson & Johnson has market leadership in sternal closure through its DePuy Synthes business. It offers a complete line of products ranging from stainless steel wires to titanium plates and hybrid systems. Its strong position in the market is backed through established clinical credibility, broad surgical expertise, and world-wide distribution capability targeting high-volume cardiac centers serving.
   
• Zimmer Biomet is committed to individualized solutions, including titanium plates, 3D-printed and low-profile sternal fixation systems for minimal invasive procedures. The products provided by the company offers increased biomechanical stability, which lowers the sternal dehiscence complications, particularly helpful with high-risk candidates like obesity or osteoporosis.
   
• KLS Martin is particularly noted for their rigid fixation systems such as the Modular Sternal Cable System and anatomical locking plates for repeat and complex sternotomies. German ingenuity in the firm couples thin, light forms with structural stiffness and minimizes hardware-caused pain.
   

Sternal Closure Systems Industry News:

• In August 2024, Johnson & Johnson announced the launch of the MatrixSTERNUM Fixation System, a plate and screw fixation solution designed to stabilize and secure the anterior chest wall following procedures such as open-heart and thoracic surgery. This strategic product introduction was expected to strengthen the company's cardiovascular portfolio.
   
• In January 2024, the U.S. FDA approved the single-use use of Able Medical's Valkyrie RIB system 510(k), a product that supplements the company's Valkyrie thoracic fixation system. The system was specifically intended for stabilizing and fixing fractures of the thoracic wall, such as sternal reconstruction, planned osteotomies, and trauma. This clearance significantly strengthened the company's regulatory standing, allowing it to build its portfolio and enhance its capacity to enter the thoracic surgical market.
   
• In January 2023, Able Medical Devices introduced the Valkyrie Looped Sternotomy Sutures, a stainless steel looped wire chest closure sutures for open-heart surgery. The launch is anticipated to enhance the company's portfolio of surgical products, meet the growing need for an established sternal closure solution, and to further establish company as a key player in cardiothoracic surgical devices.
   

The sternal closure systems market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Product

• Closure devices
  • Wires
  • Plates and screws
  • Clips and straps
• Bone cement

By Material

• Stainless steel
• Titanium
• Polyether ether ketone (PEEK)

By Procedure

• Median sternotomy
• Hemistemotomy
• Bilateral thoracotomy

By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific 
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE